Spectrum Pharma Shares Hit New High on Q4 Results – International Business Times
By Dr. Matthew Watson
 International Business Times | Spectrum Pharma Shares Hit New High on Q4 Results International Business Times The Irvine, California-based biotechnology company reported fourth quarter earnings of $4 million or 8 cents a share, down from $10 million or 20 cents a share last year. The quarterly results included, among other things, loss related to change in ... Spectrum Pharmaceuticals to Present at the 23rd Annual ROTH OC Growth Stock ...Business Wire (press release) Spectrum Pharma Q4 Profit Drops - UpdateRTT News |
Uncategorized
Comments Off on Spectrum Pharma Shares Hit New High on Q4 Results – International Business Times |
March 13th, 2011
This author published 5832 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research